Stock 002873 GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guiyang Xintian Pharmaceutical Co.,Ltd.

Equities

002873

CNE100002QB5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
10.78 CNY -1.10% Intraday chart for Guiyang Xintian Pharmaceutical Co.,Ltd. -8.41% -13.48%
Apr. 27 Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 11 Guiyang Xintian Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Guiyang Xintian Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sales of Chinese patent drugs. The Company manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Company’s main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.

Number of employees: 1,958

Sales per Business

CNY in Million2022Weight2023Weight Delta
Gynecology
70.8 %
769 70.7 % 676 70.8 % -12.08%
Urinary System
20.1 %
222 20.4 % 191 20.1 % -13.78%
Heat-clearing and Detoxification
8.5 %
80 7.4 % 81 8.5 % +1.11%
Other
0.6 %
16 1.5 % 6 0.6 % -64.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,088 100.0 % 954 100.0 % -12.29%

Managers

Managers TitleAgeSince
Da Lun Dong CEO
 Chief Executive Officer 60 95-08-10
Zhi Hui Zeng DFI
 Director of Finance/CFO 51 18-01-31
Zhong Lei He BRD
 Director/Board Member 47 21-03-31
Guang Ping Wang BRD
 Director/Board Member 54 20-08-25
Jin Hua Wang BRD
 Director/Board Member 57 95-08-10
Wei Wang IRC
 Investor Relations Contact - -
Jue Rong Chen PRN
 Corporate Officer/Principal 55 06-03-31

Members of the board

Members of the board TitleAgeSince
Da Lun Dong CEO
 Chief Executive Officer 60 95-08-10
Jin Hua Wang BRD
 Director/Board Member 57 95-08-10
Jue Rong Chen PRN
 Corporate Officer/Principal 55 06-03-31
Wen Yi Wang BRD
 Director/Board Member 51 96-05-31
Jie Zhang BRD
 Director/Board Member 50 21-09-14
Wan Xue An CHM
 Chairman 49 19-11-11
Ruzhen Jin BRD
 Director/Board Member 54 19-11-11
He Yu You BRD
 Director/Board Member 44 19-04-18
Guang Ping Wang BRD
 Director/Board Member 54 20-08-25
Zhong Lei He BRD
 Director/Board Member 47 21-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 246,677,785 134,244,413 ( 54.42 %) 15,138,117 ( 6.137 %) 54.42 %

Shareholders

NameEquities%Valuation
Rongtong Fund Management Co., Ltd.
5.026 %
11,130,000 5.026 % 18 M ¥
Zhong Geng Fund Management Co. , Ltd.
1.661 %
3,678,780 1.661 % 6 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.7739 %
1,713,700 0.7739 % 3 M ¥
AXA-SPDB Investment Managers Co., Ltd.
0.3763 %
833,415 0.3763 % 1 M ¥
China Fund Management Co., Ltd.
0.2767 %
612,845 0.2767 % 1 M ¥
Fullgoal Fund Management Co., Ltd.
0.2091 %
463,100 0.2091 % 761 656 ¥
Gfund Management Co., Ltd.
0.1633 %
361,588 0.1633 % 594 700 ¥
CITIC-Prudential Fund Management Co., Ltd.
0.0633 %
140,140 0.0633 % 230 487 ¥
Everbright PGIM Fund Management Co. Ltd.
0.0573 %
126,800 0.0573 % 208 547 ¥
Soochow Asset Management Co., Ltd.
0.0436 %
96,600 0.0436 % 158 877 ¥

Company contact information

Guiyang Xintian Pharmaceutical Co., Ltd.

3 Gaoxin North Road Wudang District

550000, Guiyang

+

http://www.gyxtyy.com
address Guiyang Xintian Pharmaceutical Co.,Ltd.(002873)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for Guiyang Xintian Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
10.78
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD. Stock Guiyang Xintian Pharmaceutical Co.,Ltd.
-13.48% 343M
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+9.28% 8.74B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-14.24% 4.94B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+49.95% 4.7B
YUHAN CORPORATION Stock Yuhan Corporation
+5.96% 3.98B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-23.57% 2.28B
INDIVIOR PLC Stock Indivior PLC
+14.18% 2.28B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+17.77% 2.14B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-32.28% 2.12B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002873 Stock
  4. Company Guiyang Xintian Pharmaceutical Co.,Ltd.